| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
10% Owner | Director, See Remarks And Footnotes | Director, See Explanation Of Responses +5 more
17 companies
Bvf Partners L P/il is a 10% Owner at CALA with holdings across 17 companies. Recent SEC Form 4 filings include 44 buys and 0 sells.
Estimated insider holdings value: $442.8M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan 12, 2023 | KYMR Kymera Therapeutics, Inc. | Director, See Remarks And Footnotes | Buy | 41,007 | $30.51 | $1,251,190.77 | +0.5% | -5.7% | -16.3% | |
| Jan 6, 2023 | XOMA Xoma Royalty Corp | Director, 10% Owner, See Remarks | Buy | 22,249 | $18.91 | $420,737.34 | +0.3% | -12.8% | -5.3% | |
| Sep 27, 2022 | XOMA Xoma Royalty Corp | Director, 10% Owner, See Remarks | Buy | 24,642 | $16.61 | $409,309.13 | +0.2% | +3.6% | -15.7% | |
| Sep 16, 2022 | XOMA Xoma Royalty Corp | Director, 10% Owner, See Remarks | Buy | 56,309 | $17.59 | $990,718.12 | +0.9% | +4.9% | -1.6% | |
| Aug 22, 2022 | KYMR Kymera Therapeutics, Inc. | Director, See Remarks And Footnotes | Buy | 545,525 | $26.00 | $14,183,650.00 | +13.5% | -9.5% | -36.2% | |
| Jun 13, 2022 | RPTX Repare Therapeutics Inc. | 10% Owner | Buy | 149,161 | $12.73 | $1,898,819.53 | +1.9% | -0.6% | -8.2% | |
| Jun 10, 2022 | OLMA Olema Pharmaceuticals, Inc. | Director, 10% Owner | Buy | 200,000 | $4.03 | $806,900.00 | +3.0% | +2.7% | +81.6% | |
| Jun 6, 2022 | RPTX Repare Therapeutics Inc. | 10% Owner | Buy | 1,836,958 | $11.90 | $21,859,328.55 | +8.5% | -15.0% | -17.4% | |
| Jun 1, 2022 | CGEM Cullinan Therapeutics, Inc. | 10% Owner | Buy | 751,396 | $11.00 | $8,264,905.16 | +11.3% | +11.5% | -10.4% | |
| May 27, 2022 | KYMR Kymera Therapeutics, Inc. | Director, See Remarks And Footnotes | Buy | 289,426 | $14.34 | $4,150,321.26 | +3.7% | +114.8% | +95.5% |